0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Meningitis Drug"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Meningitis - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Meningitis - Global Clinical Trials Review, 2024

  • Clinical Trials
  • November 2024
  • 391 Pages
  • Global
From
EUR$3,450USDGBP
Pneumococcal Meningitis - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Pneumococcal Meningitis - Global Clinical Trials Review, 2024

  • Clinical Trials
  • May 2024
  • 63 Pages
  • Global
From
EUR$2,500USDGBP
Vancomycin - Global Strategic Business Report - Product Thumbnail Image

Vancomycin - Global Strategic Business Report

  • Report
  • April 2025
  • 78 Pages
  • Global
From
EUR$5,600USDGBP
From
EUR$6,499USDGBP
From
EUR$7,950USDGBP
From
EUR$7,950USDGBP
From
EUR$7,950USDGBP
From
EUR$7,950USDGBP
From
EUR$7,950USDGBP
Meningitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Meningitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
From
EUR$3,950USDGBP
Bacterial Meningitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Bacterial Meningitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Cryptococcal Meningitis (CM) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Cryptococcal Meningitis (CM) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Meningitis - Pipeline Insight, 2024 - Product Thumbnail Image

Meningitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Neisseria Meningitides Meningitis - Pipeline Insight, 2024 - Product Thumbnail Image

Neisseria Meningitides Meningitis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 120 Pages
  • Global
From
EUR$1,500USDGBP
Cryptococcal Meningitis - Pipeline Insight, 2024 - Product Thumbnail Image

Cryptococcal Meningitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Bacterial (Pyogenic) Meningitis - Pipeline Insight, 2024 - Product Thumbnail Image

Bacterial (Pyogenic) Meningitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
From
EUR$2,500USDGBP
From
EUR$2,000USDGBP
Loading Indicator

Meningitis is an inflammation of the membranes that cover the brain and spinal cord. Meningitis drugs are used to treat the infection and reduce the risk of complications. These drugs are typically antibiotics, antivirals, or antifungals, and may be administered orally, intravenously, or intramuscularly. Commonly used antibiotics include cefotaxime, ceftriaxone, and vancomycin. Antivirals such as acyclovir and valacyclovir are used to treat viral meningitis, while antifungals such as amphotericin B and fluconazole are used to treat fungal meningitis. Meningitis drugs are part of the larger Central Nervous System (CNS) drug market, which includes drugs used to treat a variety of neurological conditions. These drugs are used to treat conditions such as epilepsy, multiple sclerosis, Parkinson's disease, and Alzheimer's disease. Some companies in the Meningitis Drug market include Pfizer, Merck, GlaxoSmithKline, Novartis, and Sanofi. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more